Rafarma Pharmaceuticals, Inc. engages in the manufacture and marketing of pharmaceutical goods. It produces all types of medical drugs in all delivery methods for various pharmacological groups. The company was founded in 1930 and is headquartered in Draper, UT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rafarma Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rafarma Pharmaceuticals Inc market cap is $3.63M.
What is the 52-week high for Rafarma Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rafarma Pharmaceuticals Inc 52 week high is $0.179 as of October 10, 2025.
What is the 52-week low for Rafarma Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rafarma Pharmaceuticals Inc 52 week low is $0.033 as of October 10, 2025.
What is Rafarma Pharmaceuticals Inc stock price today?
Rafarma Pharmaceuticals Inc stock price today is $0.039.
What was Rafarma Pharmaceuticals Inc stock price yesterday?
Rafarma Pharmaceuticals Inc stock price yesterday was $0.039.
What is the PE ratio of Rafarma Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rafarma Pharmaceuticals Inc’s P/E ratio is 11.14.
What is the Price-to-Book ratio of Rafarma Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rafarma Pharmaceuticals Inc P/B ratio is 0.3301.
What is the 50-day moving average of Rafarma Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rafarma Pharmaceuticals Inc 50-day moving average is $0.0645.
